Yale University; School of Medicine; AIDS Program
Yale University; School of Medicine; AIDS Program
New Haven, Connecticut, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) | HIV Pre-exposure Prophylaxis | Active, not recruiting | Phase 3 | 2026-08-28 | NCT07047716 | |
| Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen | HIV-1-infection | Active, not recruiting | Phase 2 / Phase 3 | 2026-08-10 | NCT05502341 | |
| Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 | HIV-1-Infection | Active, not recruiting | Phase 3 | 2026-05-29 | NCT06630299 | |
| A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection | HIV-1 Infection | Active, not recruiting | Phase 2 | 2026-04-27 | NCT05729568 |